AMG334A
Biological
Novartis Pharma AG
Total Payments
$21,636
Transactions
8
Doctors
3
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2018 | $21,636 | 8 | 3 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $18,698 | 7 | 86.4% |
| Consulting Fee | $2,938 | 1 | 13.6% |
Ad
Manufacturing Companies
- Novartis Pharma AG $21,636
Product Information
- Type Biological
- Total Payments $21,636
- Total Doctors 3
- Transactions 8
About AMG334A
AMG334A is a biological associated with $21,636 in payments to 3 healthcare providers, recorded across 8 transactions in the CMS Open Payments database. The primary manufacturer is Novartis Pharma AG.
Payment data is available from 2018 to 2018. In 2018, $21,636 was paid across 8 transactions to 3 doctors.
The most common payment nature for AMG334A is "Travel and Lodging" ($18,698, 86.4% of total).